findmyKOL

Paul Bohjanen, MD

Basic profile

University of Minnesota

ORCIDNPI
RegionMinneapolis, MN · MidwestSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 2018findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2018Online presenceNot yet checkedPaymentsNone reportedNIH funding2000–2015Why? →

Paul Bohjanen is an Infectious Disease physician affiliated with University of Minnesota. OpenAlex indexes 112 publications with 7,164 citations (h-index 43).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
112publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,164citations

Total citations across indexed works.

43h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9NIH grants · 2000–2015

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

University Of Minnesota Physicians
516 Delaware Street SE, Pwb Sixth Floor, Clinic 6b
Minneapolis, MN 55455

Telephone

612-625-4680

Registry record last updated 17 Jul 2023.

View the NPPES registry record

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    64.4%
    Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor20.2%
    Intelence100%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor19.2%
    Descovy100%
    Part D<11 patients

    + 2 more classes in this area

  • Nervous system

    18.3%
    gamma-Aminobutyric Acid A Receptor Positive Modulator18.3%
    Zolpidem Tartrate100%
    Part D<11 patients
  • Cardiovascular

    17.3%
    Statin17.3%
    Atorvastatin Calcium100%
    Part D<11 patients
Where care is delivered (Part B), 2023100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

9 NIH research awards on record, funded 20002015 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”